|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2022―Jun―14 |
Depressive symptoms and gender differences in older adults in Hong Kong during the COVID-19 pandemic: a network analysis approach |
Yu Jin, He-Li Sun, Simon Ching Lam, Zhaohui Su, Brian J. Hall, Teris Cheung, et al. (+3) Ming-Zhao Qin, Chee H. Ng, Yu-Tao Xiang |
2 |
[GO] |
2022―May―04 |
Dynamic response landscape of immune cells identified immune dysfunction which predicts disease progression in COVID-19 infected patients |
Xiangyu Deng, Yao Zhang, Meiqi Li, Xiaolong Tang, Jing Shen, Yu Chen, et al. (+10) Yueshui Zhao, Qinglian Wen, Xu Wu, Mingxing Li, Jing Li, Wenping Xu, Wanping Li, Zhangang Xiao, Deqiang Xian, Fukuan Du |
3 |
[GO] |
2022―Apr―08 |
Manifestations and Mechanism of SARS-CoV2 Mediated Cardiac Injury |
Si-chi Xu, Wei Wu, Shu-yang Zhang |
4 |
[GO] |
2022―Mar―21 |
COVID-19 receptor and malignant cancers: Association of CTSL expression with susceptibility to SARS-CoV-2 |
Lianmei Zhang, Chunli Wei, Dabing Li, Jiayue He, Shuguang Liu, Haoyue Deng, et al. (+7) Jingliang Cheng, Jiaman Du, Xiaoyan Liu, Hanchun Chen, Suan Sun, Hong Yu, Junjiang Fu |
5 |
[GO] |
2022―Feb―23 |
Immune response and potential therapeutic strategies for the SARS-CoV-2 associated with the COVID-19 pandemic |
Xianghui Li, Yabo Zhang, Libing He, Jiangzhe Si, Shuai Qiu, Yuhua He, et al. (+5) Jiacun Wei, Zhili Wang, Longxiang Xie, Yanzhang Li, Tieshan Teng |
6 |
[GO] |
2022―Feb―23 |
B.1.617.2 (Delta) Variant of SARS-CoV-2: features, transmission and potential strategies |
Yan Zhan, Hui Yin, Ji-Ye Yin |
7 |
[GO] |
2022―Feb―09 |
Virus-related Knowledge in Covid-19 Times - Results from two Cross-sectional Studies in Austria and Implications for School |
Marc Bracko, Uwe Karsten Simon |
8 |
[GO] |
2022―Jan―08 |
Human Organoids as a Promising Platform for Fighting COVID-19 |
Dong Chen, Xi Su, Haibo Chen, Siyan Chen, Yongsheng Zhao, Wei Wei |
9 |
[GO] |
2022―Jan―08 |
A systematic review of Vaccine Breakthrough Infections by SARS-CoV-2 Delta Variant |
Mengxin Zhang, Ying Liang, Dongsheng Yu, Bang Du, Weyland Cheng, Lifeng Li, et al. (+6) Zhidan Yu, Shuying Luo, Yaodong Zhang, Huanmin Wang, Xianwei Zhang, Wancun Zhang |
10 |
[GO] |
2021―Dec―15 |
The COVID-19 infection in children and its association with the immune system, prenatal stress, and neurological complications |
Suliman Khan, Rabeea Siddique, Xiao Hao, Yueting Lin, Yuxin Liu, Xiaoyan Wang, et al. (+2) Linlin Hua, Ghulam Nabi |
11 |
[GO] |
2021―Dec―15 |
Cytokine storm in COVID-19: from viral infection to immune responses, diagnosis and therapy |
Yizhou Jiang, Limor Rubin, Tangming Peng, Linlin Liu, Xingan Xing, Philip Lazarovici, Wenhua Zheng |
12 |
[GO] |
2021―Dec―15 |
COVID-19: systemic pathology and its implications for therapy |
Qi Shen, Jie Li, Zhan Zhang, Shuang Guo, Qiuhong Wang, Xiaorui An, Haocai Chang |
13 |
[GO] |
2021―Oct―04 |
COVID-19 disease and malignant cancers: The impact for the furin gene expression in susceptibility to SARS-CoV-2 |
Dabing Li, Xiaoyan Liu, Lianmei Zhang, Jiayue He, Xianmao Chen, Shuguang Liu, et al. (+5) Jiewen Fu, Shangyi Fu, Hanchun Chen, Junjiang Fu, Jingliang Cheng |
14 |
[GO] |
2021―Oct―04 |
The intraviral protein-protein interaction of SARS-CoV-2 reveals the key role of N protein in virus-like particle assembly |
Minghai Chen, Chuang Yan, Fujun Qin, Luping Zheng, Xian-En Zhang |
15 |
[GO] |
2021―Sep―06 |
Comprehensive landscape of the renin-angiotensin system in Pan-cancer: a potential downstream mediated mechanism of SARS-CoV-2 |
Yuqing Cui, Fengzhi Chen, Jiayi Gao, Mengxia Lei, Dandan Wang, Xiaoying Jin, et al. (+3) Yan Guo, Liying Shan, Xuesong Chen |
16 |
[GO] |
2021―Sep―01 |
Gene Presence/Absence Variation analysis of coronavirus family displays its pan-genomic diversity |
Du Jiao, Xiaorui Dong, Yingyan Yu, Chaochun Wei |
17 |
[GO] |
2021―Sep―01 |
Receptor-binding domain of SARS-CoV-2 spike protein efficiently inhibits SARS-CoV-2 infection and attachment to mouse lung |
Hye Jin Shin, Keun Bon Ku, Hae Soo Kim, Hyun Woo Moon, Gi Uk Jeong, Insu Hwang, et al. (+9) Gun Young Yoon, Sunhee Lee, Sumin Lee, Dae-Gyun Ahn, Kyun-Do Kim, Young-Chan Kwon, Bum-Tae Kim, Seong-Jun Kim, Chonsaeng Kim |
18 |
[GO] |
2021―Aug―06 |
RS-5645 attenuates inflammatory cytokine storm induced by SARS-CoV-2 spike protein and LPS by modulating pulmonary microbiota |
Te Liu, Jianchao Wu, Changpeng Han, Zhangbin Gong, Giuseppe La Regina, Jiulin Chen, et al. (+4) Fangfang Dou, Romano Silvestri, Chuan Chen, Zhihua Yu |
19 |
[GO] |
2021―Jul―27 |
Inhibition of SARS-CoV-2 pseudovirus invasion by ACE2 protecting and Spike neutralizing peptides: An alternative approach to COVID19 prevention and therapy |
Jiang Chen, Song Li, Zhifeng Lei, Qinmin Tang, Ling Mo, Xing Zhao, et al. (+3) Feifei Xie, Dan Zi, Jun Tan |
20 |
[GO] |
2021―Jul―27 |
Targeting the PI3K/AKT pathway: a potential new weapon in the global fight against SARS-CoV-2? |
Salvatore Santamaria |
21 |
[GO] |
2021―Jun―17 |
Capivasertib restricts SARS-CoV-2 cellular entry: a potential clinical application for COVID-19 |
Fang Sun, Chenglin Mu, Hang Fai Kwok, Jiyuan Xu, Yingliang Wu, Wanhong Liu, et al. (+5) Jean-Marc Sabatier, Cédric Annweiler, Xugang Li, Zhijian Cao, Yingqiu Xie |
22 |
[GO] |
2021―Jun―02 |
COVID-19 one year later: a retrospect of CRISPR-Cas system in combating COVID-19 |
Yan Zhan, Xiang-Ping Li, Ji-Ye Yin |
23 |
[GO] |
2021―Jun―02 |
Inflammation characteristics and anti-inflammation treatment with tocilizumab of severe/critical COVID-19 patients: A retrospective cohort study |
Qin Hu, Yu Xu, Ying Xiang, Bin Wang, Zhiquan Yuan, Yifan Shan, et al. (+9) Wenjing Zhang, Na Wu, Tingting Xia, Chengying Li, Weijia Xie, Xiaoyue Jia, Zubin Yu, Li Bai, Yafei Li |
24 |
[GO] |
2021―May―19 |
Downregulation of ACE2 expression by SARS-CoV-2 worsens the prognosis of KIRC and KIRP patients via metabolism and immunoregulation |
Qian Tang, Yue Wang, Ling Ou, Jieling Li, Kai Zheng, Hui Zhan, et al. (+7) Jiayu Gu, Guibao Zhou, Shouxia Xie, Jianping Zhang, Wei Huang, Shaoxiang Wang, Xiao Wang |
25 |
[GO] |
2021―Apr―12 |
The continued global battle against SARS-CoV-2 and COVID-19 |
Chu-Xia Deng |
26 |
[GO] |
2021―Apr―12 |
Development and application of therapeutic antibodies against COVID-19 |
Lin Ning, Hamza B. Abagna, Qianhu Jiang, Siqi Liu, Jian Huang |
27 |
[GO] |
2021―Apr―12 |
Developing effective siRNAs to reduce the expression of key viral genes of COVID-19 |
Renfei Wu, Kathy Qian Luo |
28 |
[GO] |
2021―Apr―12 |
Glucocorticoids are double-edged sword in the treatment of COVID-19 and cancers |
Ruixin Yang, Yingyan Yu |
29 |
[GO] |
2021―Apr―12 |
From impossible to possible: the lessons from the control of recent COVID-19 outbreaks in China |
Lixin Tai, Kengieng Wong, Li Wang, Li-jun Di |
30 |
[GO] |
2021―Apr―12 |
Krebs Von den Lungen-6 as a predictive indicator for the risk of secondary pulmonary fibrosis and its reversibility in COVID-19 patients |
Mingshan Xue, Teng Zhang, Hao Chen, Yifeng Zeng, Runpei Lin, Yingjie Zhen, et al. (+7) Ning Li, Zhifeng Huang, Haisheng Hu, Luqian Zhou, Hui Wang, Xiaohua Douglas Zhang, Baoqing Sun |
31 |
[GO] |
2021―Apr―12 |
Review of Covid-19 vaccine clinical trials - A puzzle with missing pieces |
Hang Fai Kwok |
32 |
[GO] |
2021―Apr―12 |
Attitudes toward COVID-19 vaccines in Chinese college students |
Wei Bai, Hong Cai, Shou Liu, Huanzhong Liu, Han Qi, Xu Chen, et al. (+5) Rui Liu, Teris Cheung, Zhaohui Su, Chee H. Ng, Yu-Tao Xiang |
33 |
[GO] |
2021―Apr―12 |
Artificial intelligence in the diagnosis of COVID-19: challenges and perspectives |
Shigao Huang, Jie Yang, Simon Fong, Qi Zhao |
34 |
[GO] |
2021―Apr―12 |
The role of CD4+FoxP3+ regulatory T cells in the immunopathogenesis of COVID-19: implications for treatment |
Yifei Wang, Jingbin Zheng, Md Sahidul Islam, Yang Yang, Yuanjia Hu, Xin Chen |
35 |
[GO] |
2021―Apr―12 |
Hydroxychloroquine/Chloroquine as Therapeutics for COVID-19: Truth under the Mystery |
Yao Chen, Mei-Xiu Li, Guo-Dong Lu, Han-Ming Shen, Jing Zhou |
36 |
[GO] |
2021―Apr―12 |
mRNA vaccines for COVID-19: what, why and how |
Jung Woo Park, Philip N.P. Lagniton, Yu Liu, Ren-He Xu |
37 |
[GO] |
2021―Apr―12 |
Global landscape of patents related to human coronaviruses |
Kunmeng Liu, Zixuan Gu, Md Sahidul Islam, Thomas Scherngell, Xiangjun Kong, Jing Zhao, et al. (+2) Xin Chen, Yuanjia Hu |
38 |
[GO] |
2021―Apr―12 |
In silico structure-based discovery of a SARS-CoV-2 main protease inhibitor |
Lei Wen, Kaiming Tang, Kenn Ka-Heng Chik, Chris Chun-Yiu Chan, Jessica Oi-Ling Tsang, Ronghui Liang, et al. (+11) Jianli Cao, Yaoqiang Huang, Cuiting Luo, Jian-Piao Cai, Zi-Wei Ye, Feifei Yin, Hin Chu, Dong-Yan Jin, Kwok-Yung Yuen, Shuofeng Yuan, Jasper Fuk-Woo Chan |
39 |
[GO] |
2021―Apr―12 |
SARS-CoV-2 main protease suppresses type I interferon production by preventing nuclear translocation of phosphorylated IRF3 |
Sin-Yee Fung, Kam-Leung Siu, Huayue Lin, Man Lung Yeung, Dong-Yan Jin |
40 |
[GO] |
2021―Apr―12 |
Construction and applications of SARS-CoV-2 pseudoviruses: a mini review |
Minghai Chen, Xian-En Zhang |
41 |
[GO] |
2021―Apr―12 |
SARS-CoV-2-induced Overexpression of miR-4485 Suppresses Osteogenic Differentiation and Impairs Fracture Healing |
Bobin Mi, Yuan Xiong, Chenming Zhang, Wu Zhou, Lang Chen, Faqi Cao, et al. (+6) Fenghua Chen, Zhi Geng, Adriana C. Panayi, Yun Sun, Lin Wang, Guohui Liu |
42 |
[GO] |
2021―Apr―12 |
The Genetic Variant of SARS-CoV-2: Would it matter for Controlling the Devastating Pandemic? |
Shuxin Guo, Kefang Liu, Jun Zheng |
43 |
[GO] |
2021―Mar―16 |
Should people with severe mental illness be prioritized for the COVID-19 vaccination? |
Yuan Yang, Wen Li, Qinge Zhang, Ling Zhang, Teris Cheung, Chee H Ng, Yu-Tao Xiang |
44 |
[GO] |
2021―Mar―16 |
Inflammatory stress in SARS-COV-2 associated Acute Kidney Injury |
Junzhe Chen, Wenbiao Wang, Ying Tang, Xiao-ru Huang, Xueqing Yu, Hui-Yao Lan |
45 |
[GO] |
2021―Mar―16 |
Assessment of global asymptomatic SARS-CoV-2 infection and management practices from China |
Zheng Chen, Bili Wang, Shanshan Mao, Qing Ye |
46 |
[GO] |
2021―Feb―19 |
Evaluation and characterization of HSPA5 (GRP78) expression profiles in normal individuals and cancer patients with COVID-19 |
Jiewen Fu, Chunli Wei, Jiayue He, Lianmei Zhang, Ju Zhou, Kyathegowdanadoddi Srinivasa Balaji, et al. (+4) Shiyi Shen, Jiangzhou Peng, Amrish Sharma, Junjiang Fu |
47 |
[GO] |
2021―Feb―19 |
Depression and its relationship with quality of life in frontline psychiatric clinicians during the COVID-19 pandemic in China: a national survey |
Hong-He Zhang, Yan-Jie Zhao, Chun Wang, Qinge Zhang, Hai-Yang Yu, Teris Cheung, et al. (+3) Brian J. Hall, Feng-Rong An, Yu-Tao Xiang |
48 |
[GO] |
2021―Jan―31 |
A rapid screening classifier for diagnosing COVID-19 |
Yang Xia, Weixiang Chen, Hongyi Ren, Jianping Zhao, Lihua Wang, Rui Jin, et al. (+13) Jiesen Zhou, Qiyuan Wang, Fugui Yan, Bin Zhang, Jian Lou, Shaobin Wang, Xiaomeng Li, Jie Zhou, Liming Xia, Cheng Jin, Jianjiang Feng, Wen Li, Huahao Shen |
49 |
[GO] |
2020―Nov―06 |
ACE2 Correlated With Immune Infiltration Serves As A Novel Prognostic Biomarker In Clear Cell Renal Cell Carcinoma: Implication For COVID-19 |
Wuping Yang, Lei Li, Kenan Zhang, Kaifang Ma, Haibiao Xie, Yanqing Gong, et al. (+2) Jingcheng Zhou, Kan Gong |
50 |
[GO] |
2020―Nov―06 |
A Multiple-Hit Hypothesis Involving Reactive Oxygen Species and Myeloperoxidase Explains Clinical Deterioration and Fatality in COVID-19 |
Pravin T Goud, David Bai, Husam M Abu-Soud |
51 |
[GO] |
2020―Nov―06 |
Clinical characteristics and analysis of risk factors for disease progression of COVID-19: A retrospective Cohort Study |
Zhengtong Lv, Shubin Lv |
52 |
[GO] |
2020―Nov―06 |
Current advances in the development of SARS-CoV-2 vaccines |
Annoor Awadasseid, Yanling Wu, Yoshimasa Tanaka, Wen Zhang |
53 |
[GO] |
2020―Nov―06 |
SARS-CoV-2 variants evolved during the early stage of the pandemic and effects of mutations on adaptation in Wuhan populations |
Annoor Awadasseid, Yanling Wu, Yoshimasa Tanaka, Wen Zhang |
54 |
[GO] |
2020―Oct―09 |
Comprehensive analysis of two potential novel SARS-CoV-2 entries, TMPRSS2 and IFITM3, in healthy individuals and cancer patients |
Yu-Jun Dai, Wei-Na Zhang, Wei-Da Wang, Si-Yuan He, Cheng-Cai Liang, Da-Wei Wang |
55 |
[GO] |
2020―Sep―25 |
Update of the current knowledge on genetics, evolution, immunopathogenesis, and transmission for coronavirus disease 19 (COVID-19) |
Kalthoum Tizaoui, Ines Zidi, Keum Hwa Lee, Ramy Abou Ghayda, Sung Hwi Hong, Han Li, et al. (+5) Lee Smith, Ai Koyanagi, Louis Jacob, Andreas Kronbichler, Jae Il Shin |
56 |
[GO] |
2020―Sep―11 |
Disease knowledge and attitudes during the COVID-19 epidemic among international migrants in China: a national cross-sectional study |
Cheng Wang, Qi Tian, Peizhen Zhao, Mingzhou Xiong, Carl A Latkin, Yiqun Gan, et al. (+2) Brian J Hall, Bin Yang |
57 |
[GO] |
2020―Sep―08 |
The development of the 'COVID-19 Psychological Resilience Model' and its efficacy during the COVID-19 pandemic in China |
Zongling He, Jiajia Chen, Keliang Pan, Yuchuan Yue, Teris Cheung, Yin Yuan, et al. (+9) Na Du, Yan Zhao, Yusu Feng, Die Zhou, You Zhou, Fengmei Lu, Yong Chen, Manxi He, Yu-Tao Xiang |
58 |
[GO] |
2020―Sep―08 |
COVID-19: Insight into the asymptomatic SARS-COV-2 infection and transmission |
Dongsheng Han, Rui Li, Yanxi Han, Rui Zhang, Jinming Li |
59 |
[GO] |
2020―Jul―24 |
Bioinformatic Analysis of Correlation between Immune Infiltration and COVID-19 in Cancer Patients |
Xin Huang, Chaobin He, Xin Hua, Anna Kan, Shuxin Sun, Jun Wang, Shengping Li |
60 |
[GO] |
2020―Jul―24 |
Glucocorticoids save lives in COVID-19 patients |
Chu-Xia Deng |
61 |
[GO] |
2020―Jul―24 |
Immune Response and COVID-19: A mirror image of Sepsis |
Eduardo López-Collazo, José Avendaño-Ortiz, Alejandro Martín-Quirós, Luis A. Aguirre |
62 |
[GO] |
2020―Jul―02 |
Glucocorticoids improve severe or critical COVID-19 by activating ACE2 and reducing IL-6 levels |
Zhen Xiang, Jialin Liu, Dake Shi, Wei Chen, Jun Li, Ranlin Yan, et al. (+5) Yufang Bi, Weiguo Hu, Zhenggang Zhu, Yingyan Yu, Zhitao Yang |
63 |
[GO] |
2020―Jun―15 |
An overview of the expert consensus on the mental health treatment and services for major psychiatric disorders during COVID-19 outbreak: China's experiences |
Yu-Tao Xiang, Na Zhao, Yan-Jie Zhao, Zihan Liu, Qinge Zhang, Yuan Feng, et al. (+3) Xiao-Na Yan, Teris Cheung, Chee H. Ng |
64 |
[GO] |
2020―May―03 |
A potential treatment of COVID-19 with TGF-β blockade |
WanJun Chen |
65 |
[GO] |
2020―Apr―11 |
Initial success in the identification and management of the coronavirus disease 2019 (COVID-19) indicates human-to-human transmission in Wuhan, China |
Annoor Awadasseid, Yanling Wu, Yoshimasa Tanaka, Wen Zhang |
66 |
[GO] |
2020―Mar―21 |
The global battle against SARS-CoV-2 and COVID-19 |
Chu-Xia Deng |
67 |
[GO] |
2020―Mar―21 |
Targeting the Endocytic Pathway and Autophagy Process as a Novel Therapeutic Strategy in COVID-19 |
Naidi Yang, Han-Ming Shen |
68 |
[GO] |
2020―Mar―21 |
Tribute to health workers in China: A group of respectable population during the outbreak of the COVID-19 |
Yu-Tao Xiang, Yu Jin, Yu Wang, Qinge Zhang, Ling Zhang, Teris Cheung |
69 |
[GO] |
2020―Mar―21 |
Knowledge, attitudes, and practices towards COVID-19 among Chinese residents during the rapid rise period of the COVID-19 outbreak: a quick online cross-sectional survey |
Bao-Liang Zhong, Wei Luo, Hai-Mei Li, Qian-Qian Zhang, Xiao-Ge Liu, Wen-Tian Li, Yi Li |
70 |
[GO] |
2020―Mar―21 |
Evaluation of SARS-CoV-2 RNA shedding in clinical specimens and clinical characteristics of 10 patients with COVID-19 in Macau |
Iek Long Lo, Chon Fu Lio, Hou Hon Cheong, Chin Ion Lei, Tak Hong Cheong, Xu Zhong, et al. (+2) Yakun Tian, Nin Ngan Sin |
71 |
[GO] |
2020―Mar―21 |
The COVID-19 outbreak and psychiatric hospitals in China: managing challenges through mental health service reform |
Yu-Tao Xiang, Yan-Jie Zhao, Zi-Han Liu, Xiao-Hong Li, Na Zhao, Teris Cheung, Chee H. Ng |
72 |
[GO] |
2020―Mar―21 |
Progression of Mental Health Services during the COVID-19 Outbreak in China |
Wen Li, Yuan Yang, Zi-Han Liu, Yan-Jie Zhao, Qinge Zhang, Ling Zhang, et al. (+2) Teris Cheung, Yu-Tao Xiang |
73 |
[GO] |
2020―Mar―21 |
COVID-19: what has been learned and to be learned about the novel coronavirus disease |
Ye Yi, Philip N.P. Lagniton, Sen Ye, Enqin Li, Ren-He Xu |
74 |
[GO] |
2020―Mar―21 |
Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2 |
Guangyu Zhou, Qi Zhao |
75 |
[GO] |
2020―Mar―21 |
Traditional Chinese Medicine in the Treatment of Patients Infected with 2019-New Coronavirus (SARS-CoV-2): A Review and Perspective |
Yang Yang, Md Shahidul Islam, Jin Wang, Yuan Li, Xin Chen |
76 |
[GO] |
2020―Mar―21 |
SARS-CoV-2: an Emerging Coronavirus that Causes a Global Threat |
Jun Zheng |
77 |
[GO] |
2020―Mar―21 |
Zoonotic origins of human coronaviruses |
Zi-Wei Ye, Shuofeng Yuan, Kit-San Yuen, Sin-Yee Fung, Chi-Ping Chan, Dong-Yan Jin |